{"slideshow_credits": null, "snippet": "India, the second-largest exporter of over-the-counter and prescription drugs to the United States, is coming under increased scrutiny by American regulators.", "abstract": "India has come under increased scrutiny by American regulators for safety lapses, falsified drug test results and selling fake medicines; Food and Drug Administration investigation blitz of pharmaceutical industry there, which is second-largest exporter of over-the-counter and prescription drugs to the United States, has led to flood of new penalties, alarming Indian officials and executives who say manufacturers may not be able to continue operations.", "section_name": "World", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Gardiner", "role": "reported", "lastname": "HARRIS", "rank": 1, "organization": ""}], "original": "By GARDINER HARRIS", "contributor": "Denise Grady contributed reporting from Kampala, Uganda, and Hari Kumar from Srinagar, Kashmir."}, "web_url": "http://www.nytimes.com/2014/02/15/world/asia/medicines-made-in-india-set-off-safety-worries.html", "lead_paragraph": "India, the second-largest exporter of over-the-counter and prescription drugs to the United States, is coming under increased scrutiny by American regulators.", "headline": {"main": "Medicines Made in India Set Off Safety Worries", "print_headline": "Medicines Made in India Set Off Safety Worries"}, "_id": "52fece1138f0d826f8460e57", "word_count": "1433", "multimedia": [{"height": 126, "url": "images/2014/02/15/world/jp-drugs2/jp-drugs2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/02/15/world/jp-drugs2/jp-drugs2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 376, "url": "images/2014/02/15/world/sub-jp-drugs-1/sub-jp-drugs-1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/02/15/world/sub-jp-drugs-1/sub-jp-drugs-1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "376"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/02/15/world/sub-jp-drugs-1/sub-jp-drugs-1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/02/15/world/sub-jp-drugs-1/sub-jp-drugs-1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-02-15T00:00:00Z", "source": "The New York Times", "news_desk": "Foreign", "keywords": [{"value": "Regulation and Deregulation of Industry", "name": "subject", "is_major": "N", "rank": "11"}, {"value": "Ranbaxy Laboratories", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Cipla Ltd", "name": "organizations", "is_major": "N", "rank": "8"}, {"value": "Recalls and Bans of Products", "name": "subject", "is_major": "N", "rank": "10"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Fines (Penalties)", "name": "subject", "is_major": "N", "rank": "12"}, {"value": "India", "name": "glocations", "is_major": "Y", "rank": "3"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "N", "rank": "7"}, {"value": "International Trade and World Market", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Hamburg, Margaret A", "name": "persons", "is_major": "N", "rank": "6"}, {"value": "Counterfeit Merchandise", "name": "subject", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": "Asia Pacific", "type_of_material": "News"}